Schmid Laboratories, Inc. et al. Seek Hearing on FDA Proposal to Withdraw Approval of Five New Drug Applications

Summary

The FDA is offering a chance for a hearing on its plan to revoke the approval of five new drug applications submitted by multiple companies, following repeated failure to submit required annual reports